Skip to main content

Table 2 Current status of clinical trials of CIK cells

From: Cytokine-induced killer (CIK) cells: from basic research to clinical translation

Target disease

Registered trial

Phase

Combined treatment

Enrolled patients (cases)

Lung cancer

NCT01498055

II/III

None

120

NCT01631357

II/III

Chemotherapy

200

Small cell lung cancer

NCT01592422

II

Best supportive care

60

NCT01481259

II/III

Chemotherapy

120

Non-small cell lung cancer

NCT01902875

Undefined

Chemotherapy

100

NCT01871480

II

Gefitinib

50

Hepatocellular carcinoma

NCT01821482

II

DC

100

NCT01758679

IV

Chemotherapy

120

NCT01749865

III

None

200

NCT00769106

III

None

200

Renal cell carcinoma

NCT01924156

I/II

Adenovirus-transfected autologous DC

30

NCT00862303

I/II

DC + cytokines

100

NCT01240005

I/II

None

30

Nasopharyngeal carcinoma

NCT01655628

II

Chemotherapy

40

NCT01821495

II

DC

100

Esophageal carcinoma

NCT01691625

Undefined

Chemoradiotherapy + DC

50

NCT01691664

Undefined

Radiotherapy + DC

40

Colorectal cancer

NCT01839539

II

DC

60

NCT02202928

II

Chemoradiotherapy + DC

60

NCT01929499

II

None

210

Gastric cancer

NCT02215837

II

DC

40

NCT01783951

I/II

Chemotherapy + DC

70

Pancreatic cancer

NCT01781520

I/II

Chemotherapy + DC

30

Cholangiocarcinoma

NCT01868490

I/II

None

13

High-risk soft tissue sarcoma

NCT01898663

I/II

Adenovirus-transfected autologous DC

30

Malignant glioma

NCT01235845

I/II

DC

30

Triple negative breast neoplasms

NCT01395056

Undefined

Chemotherapy + DC

50

Solid tumor

NCT01914263

I

None

40

Solid tumor and B-cell lymphoma

NCT01799083

I/II

Chemotherapy

100

Hematologic malignancies

NCT00460694

I/II

None

20

NCT00477035

I/II

Chemotherapy

22

NCT01186809

II

None

39

NCT00186342

Undefined

Ablative allo-HCT

120

Multiple myeloma

NCT00185757

I

None

20

Acute leukemia

NCT01956630

I/II

Genetically modified DC

25

Chronic myeloid leukemia

NCT00815321

II

None

11

Acute myeloid leukemia and myelodysplastic syndrome

NCT00394381

I/II

None

17

Myelodysplastic syndrome

NCT01392989

II

Chemotherapy

21

Lymphoma

NCT01828008

Undefined

None

20

Malignant tumor

NCT01884168

Undefined

DC

30

  1. These data were searched on 15 July 2014 from the website ClinicalTrials.gov (http://www.clinicaltrials.gov). The key word “cytokine-induced killer cells” was used. DC, dendritic cells; HCT, hematopoietic cell transplantation.